Email This Article

Exubera Success May Hinge on Usability
By Robert Steyer
06/30/06 - 02:59 PM EDT
Pfizer and Nektar will know soon enough if diabetics are ready to make the switch from injections to inhaled insulin.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,270.78 1,087.28 2,164.57 34.38
Oil *
72.21
DOWN
15.19
DOWN
4.65
DOWN
8.42
UP
0.46
10 Yr
3.44%
SPDR Gold
109.84
-0.15%
-0.43%
-0.39%
+1.36%
Data delayed 20 minutes

Brokerage Partners